Kelzy

Dienogest/Ethinylestradiol, the active ingredients in Kelzy, are a combined oral contraceptive presented as an oral tablet for oral use. It prevents pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus. It is also indicated for contraception and may help regulate menstrual cycles and improve acne.

GNH USA supplies Kelzy as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets, with reliable logistics and documentation support throughout.

Kelzy is a combined oral contraceptive that acts on the reproductive hormone axis to prevent pregnancy and manage hormone‑related menstrual conditions.

Contraception: prevents pregnancy by inhibiting ovulation and altering cervical mucus. Menstrual cycle regulation: helps establish regular menstrual periods. Acne improvement: may reduce androgen‑related acne in women.

Kelzy may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild stomach upset, often resolves with continued use. - Headache: occasional tension‑type headache. - Breast tenderness: temporary swelling or discomfort. - Breakthrough bleeding: spotting between periods. - Mood changes: mild irritability or mood swings. - Weight gain: modest increase in body weight.

Serious or Rare Side Effects: - Venous thromboembolism: deep‑vein clot formation. - Arterial thrombosis: risk of heart attack or stroke. - Severe hypertension: sudden increase in blood pressure. - Liver tumor: rare hepatic adenoma. - Severe allergic reaction: rash, swelling, or anaphylaxis.

Before prescribing Kelzy, clinicians should evaluate individual risk factors and contraindications. - Pregnancy: discontinue immediately if pregnancy is confirmed. - Smoking over age 35: avoid due to increased cardiovascular risk. - Cardiovascular disease: assess history of thrombosis or hypertension. - Liver disease: use with caution in hepatic impairment. - Drug interactions: review concomitant medications for enzyme‑inducing agents. - Store at ambient temperature: keep below 25°C, protect from moisture and light.

Kelzy can interact with several medicines, altering its effectiveness or increasing adverse event risk.

Major Interactions (Avoid): - Enzyme inducers (e.g., rifampin, carbamazepine): may reduce contraceptive efficacy. - Antiretrovirals (e.g., protease inhibitors): can affect hormone levels. - St. John’s wort: may diminish contraceptive protection.

Moderate Interactions (Monitor Closely): - Antifungals (e.g., ketoconazole): may increase hormone concentrations. - Antidepressants (SSRIs): may raise bleeding risk. - Diuretics: can exacerbate hypertension, requiring blood pressure monitoring.